Impact of serum lipids and risks of cardiovascular disease due to use of sertraline- case series study

• In: Poster presentation
• At: Seoul (South Korea) (2017)
• Type: Poster
• Poster code: POS-HPS-143
• By: WU, Shan-Chieh (Mennonite Christian Hospital, Pharmacy, Hualien, China Taiwan)
• Co-author(s): Shan-Chieh Wu: Pharmacy, Mennonite Christian Hospital, Hualien, Taiwan, Province of China
  Hsiang-Wen Lin: School of pharmacy, China Medical University, Taichung, Taiwan, Province of China
  Yu-Wan Cheng: Pharmacy, Mennonite Christian Hospital, Hualien, Taiwan, Province of China
  
• Abstract:

  Background

  Few evidence indicates associations of changing lipids after using second-generation antipsychotics. Furthermore, there is limited evidence about increasing risks of cardiovascular disease (CVD) due to changing of the lipid profiles (i.e., elevation of total cholesterol (TC), triglycerides (TG) or reduction of high-density lipoprotein..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login